Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 446
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02574819 | Study of Methylnaltrexone in Opioid-Induced Constipation Patients | ||
| NCT02752516 | A Phase I Additional Study of Anlotinib on Tolerance and Pharmacokinetics | ||
| NCT06031480 | Anlotinib and TQB2450 in Advanced Hepatocellular Carcinoma After Failure of Prior Immune Checkpoint Inhibitors | ||
| NCT06085053 | A Clinical Trial of TQA3038 Injection in Healthy Adult Subjects | ||
| NCT05735496 | Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers | ||
| NCT05862337 | Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence. | ||
| NCT02586337 | Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032) | ||
| NCT05033587 | Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma. | ||
| NCT07512596 | Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria | ||
| NCT05192512 | Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers | ||
| NCT06821503 | Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C | ||
| NCT06767813 | Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms | ||
| NCT04340427 | A Study of TQB3455 Tablets in Subjects With Advanced Malignancies | ||
| NCT06748079 | A Clinical Study of TQC3721 Inhalation Powder in Patients With Chronic Obstructive Pulmonary Disease | ||
| NCT02332499 | Study of Anlotinib in Patients With Metastatic Colorectal Cancer（mCRC）(ALTER0703) | ||
| NCT06156280 | A Clinical Study of TQH2929 in Healthy Adult Subjects | ||
| NCT07407803 | Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas | ||
| NCT06433531 | A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP) | ||
| NCT07545213 | Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis | ||
| NCT07269145 | A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3122 Capsules in Subjects With Advanced Malignant Tumors | ||
| NCT06542614 | Treatment of Moderate to Severe Plaque Psoriasis | ||
| NCT04804904 | A Pharmacokinetic Study of TQB3101 in Chinese Healthy Subjects | ||
| NCT06198751 | A Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer | ||
| NCT02622932 | Study to Investigate the Absorption, Metabolism and Excretion of [14C] Anlotinib in Patients With Advanced Cancer Patients | ||
| NCT06431490 | A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer | ||
| NCT04796623 | A Study of TQB3616 Capsules Combined With Fulvestrant Injection in Subjects With Advanced Breast Cancer | ||
| NCT01833923 | A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics | ||
| NCT06507891 | A Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets | ||
| NCT04213118 | Anlotinib Combined With TACE in Hepatocellular Carcinoma Patients at High Risk of Post Surgery Recurrence | ||
| NCT05866510 | Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal Cancer | ||
| NCT06662760 | Clinical Trial of TQB3002 in Patients With Advanced Cancers | ||
| NCT06566248 | A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside (Acid) Analogues in Patients With Primary/Treated Chronic Hepatitis B | ||
| NCT04325776 | A Study of AL2846 Versus Zoledronic Acid in Subjects With Advanced Non-Small Cell Lung Cancer With Bone Metastasis | ||
| NCT05849727 | A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis | ||
| NCT04128085 | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3804 in Subjects With Advanced Malignant Tumors | ||
| NCT05375461 | TQB3616 Capsules Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer in Clinical Trail | ||
| NCT07385703 | Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma. | ||
| NCT06429397 | Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma | ||
| NCT07147946 | Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease | ||
| NCT07482592 | Clinical Trial of TQB3205 Capsule in Subjects With Advanced Malignant Tumors | ||
| NCT06139367 | A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects | ||
| NCT04325763 | A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC) | ||
| NCT04061109 | Safety, Efficacy Evaluation of Recombinant Coagulation Factor VIII Injection in Subjects With Hemophilia A. | ||
| NCT06010901 | A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer. | ||
| NCT05765357 | Clinical Study to Compare the Pharmacokinetics and Safety of Trastuzumab for Injection With Herceptin® in Healthy Male Volunteers | ||
| NCT06475599 | Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer | ||
| NCT06431438 | Study to Evaluate the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of TQA3810 Tablets | ||
| NCT04941404 | A Study of TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD) | ||
| NCT02449343 | Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203) | ||
| NCT07338838 | To Evaluate the Tolerability and Pharmacokinetics of TQB3142 for Injection in Patients With Advanced Malignant Tumors |
